Skip to content

A Study on the Effectiveness of Haritaki (Terminalia chebula) Along with Homoeopathic Treatment in Managing Piles

To Evaluate The Efficacy Of Terminalia Chebula Mother Tincture As An Adjuvant In Comparison With Individualized Homoeopathic Medicine In The Management Of Hemorrhoids-A Prospective open Labelled Double Arm Randomized Control Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110623
Enrollment
60
Registered
2026-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K641- Second degree hemorrhoids

Interventions

Intervention1: Terminalia chebula mother tincture as adjuvant therapy: Terminalia chebula mother tincture will be administered in 15-20 drops dosage, frequency- twice a day, Route of administration- O

Sponsors

J s p s Government Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of all sex, race, ethnicity All chronic cases with age group between 20-60 years Patients who expressed their willingness to participate in the study through signed consent form

Exclusion criteria

Exclusion criteria: Subjects with age below 8 and above 70 years of age Patients suffering with terminal illness Acute emergency cases Hemorrhoids with thrombosis Where the patients are using other system of medicine for the above condition

Design outcomes

Primary

MeasureTime frame
To assess and compare the reduction in hemorrhoidal symptoms between patients treated with individualizes homoeopathic medicineTimepoint: Baseline , 6 months

Secondary

MeasureTime frame
Terminalia chebula mother tincture and those treated with individualized homoeopathic medicine aloneTimepoint: 24 months

Countries

India

Contacts

Public ContactDRJVinod kumar

J.S.P.S Government Homoeopathic Medical College-211

pindigamaharshiraghava@gmail.com9515533830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026